Related Experiment Video

Updated: Sep 27, 2026

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

Omega-3 fatty acids: implications for the treatment of tumor-associated inflammation

David Jho1, Tricia A Babcock, W Scott Helton

  • 1Department of Surgery, University of Illinois at Chicago, Chicago, Illinois 60612, USA.

The American Surgeon
|February 11, 2003
PubMed

Insights

Omega-3 fatty acids (FA) show significant anti-inflammatory effects, offering potential clinical benefits for chronic inflammatory conditions and malignancies. Further research explores their biological impacts and mechanisms of action.

Area of Science:

  • Nutritional science
  • Biochemistry
  • Immunology

Background:

  • Chronic inflammatory diseases and malignancies lack effective nutritional therapies.
  • Omega-3 fatty acids (FA) are recognized for their potential health benefits.

Purpose of the Study:

  • To investigate the biological effects of omega-3 FA.
  • To elucidate the mechanisms behind their anti-inflammatory actions.
  • To highlight the clinical potential of omega-3 FA in diseases.

Main Methods:

  • In vivo studies.
  • In vitro experiments.
  • Literature review and data synthesis.

Main Results:

  • Omega-3 FA demonstrate notable anti-inflammatory properties.
  • Specific biological pathways and mechanisms of action have been identified.
  • The research supports the therapeutic potential of omega-3 FA.

Conclusions:

  • Omega-3 FA represent a promising nutritional therapy for inflammatory conditions and cancer.
  • Understanding their mechanisms can optimize clinical applications.
  • Further research is warranted to fully harness their therapeutic potential.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...